Synergistic Effect of the Combined Action of Targeted and Photodynamic Therapy on HER2-Positive Breast Cancer

被引：0
作者：
I. V. Balalaeva
L. V. Krylova
M. A. Karpova
A. A. Shulga
E. V. Konovalova
E. L. Guryev
S. M. Deyev
机构：
[1] Lobachevsky State University of Nizhny Novgorod,
[2] Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry,undefined
[3] Russian Academy of Sciences,undefined
[4] Sechenov First Moscow State Medical University,undefined
来源：
Doklady Biochemistry and Biophysics | 2022年 / 507卷
关键词：
targeted therapy; recombinant anticancer toxin; DARPin-LoPE; photodynamic therapy; photodithazine; breast cancer; HER2 receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：330 / 333
页数：3
相关论文
共 50 条
  • [31] Neratinib in HER2-Positive Breast Cancer Patients
    Paranjpe, Rutugandha
    Basatneh, Dima
    Tao, Gabriel
    De Angelis, Carmine
    Noormohammed, Sobia
    Ekinci, Ekim
    Abughosh, Susan
    Ghose, Romi
    Trivedi, Meghana V.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (06) : 612 - 620
  • [32] Preoperative treatment of HER2-positive breast cancer
    Wysocki, Piotr J.
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2020, 16 (02): : 69 - 74
  • [33] Her2-positive breast cancer: Herceptin and beyond
    Dean-Colomb, Windy
    Esteva, Francisco J.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (18) : 2806 - 2812
  • [34] The Adjuvant Treatment of HER2-Positive Breast Cancer
    Danijela Jelovac
    Antonio C. Wolff
    Current Treatment Options in Oncology, 2012, 13 : 230 - 239
  • [35] The Adjuvant Treatment of HER2-Positive Breast Cancer
    Jelovac, Danijela
    Wolff, Antonio C.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (02) : 230 - 239
  • [36] Pyrotinib as a therapeutic for HER2-positive breast cancer
    Kioutchoukova, Ivelina
    Lucke-Wold, Brandon P.
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (06) : 1376 - 1379
  • [37] Personalized medicine for HER2-positive breast cancer
    Wang, Zhixiang
    BREAST CANCER MANAGEMENT, 2015, 4 (05) : 237 - 240
  • [38] Hormonotherapy in patients with HER2-positive breast cancer
    Debska, Sylwia
    Potemski, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2010, 6 (06): : 301 - 310
  • [39] Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivo
    Conlon, Neil
    Roche, Sandra
    Mahdi, Amira F.
    Browne, Alacoque
    Breen, Laura
    Gaubatz, Johanna
    Meiller, Justine
    O'Neill, Fiona
    O'Driscoll, Lorraine
    Cremona, Mattia
    Hennessy, Bryan
    Eli, Lisa
    Crown, John
    Collins, Denis M.
    TRANSLATIONAL ONCOLOGY, 2024, 49
  • [40] HER2-Positive Inflammatory Breast Cancer Challenges of Clinical Practices
    Magalhaes, Denise
    Rangel, Ines
    Mesquita, Alexandra
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
12345